Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?
Year-to-date chart of Evoke Pharma stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement triggered a dramatic spike to new highs, bringing the stock roughly back to breakeven for the yeartipranks.com.